Staar Surgical Company (STAA) Stock Price, Quote & News

Latest News on STAA

May 22, 2025, 7:00 AM EDT - 15 days ago

STAAR Surgical Announces Participation in Upcoming Investor Conferences

May 16, 2025, 7:00 AM EDT - 21 days ago

STAAR Surgical Announces $30 Million Share Repurchase Authorization

May 14, 2025, 4:08 AM EDT - 24 days ago

STAAR Surgical Q1: Clouded Outlook Warrants Caution (Rating Downgrade)

May 7, 2025, 11:51 PM EDT - 4 weeks ago

STAAR Surgical Company (STAA) Q1 2025 Earnings Call Transcript

May 7, 2025, 4:01 PM EDT - 4 weeks ago

STAAR Surgical Reports First Quarter 2025 Results

Apr 24, 2025, 5:00 PM EDT - 6 weeks ago

STAAR Surgical Announces Changes to Board of Directors

Apr 23, 2025, 7:00 AM EDT - 6 weeks ago

STAAR Surgical to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025

Mar 17, 2025, 6:30 PM EDT - 2 months ago

STAAR Surgical Announces Realignment of Leadership Structure

Mar 2, 2025, 11:00 AM EST - 3 months ago

The Schall Law Firm Invites Shareholders With Losses In STAAR Surgical Company To Join A Securities Fraud Investigation

Feb 27, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages STAAR Surgical Company (STAA) Shareholders to Inquire about Securities Investigation

Feb 26, 2025, 4:45 PM EST - 3 months ago

STAAR Surgical Announces Leadership Transition

Feb 26, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating STAAR Surgical Company (STAA) And Encourages Shareholders to Connect

Feb 25, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against STAAR Surgical Company (STAA) And Encourages Shareholders to Reach Out

Feb 24, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against STAAR Surgical Company (STAA) and Encourages Shareholders to Learn More About the Investigation

Feb 23, 2025, 10:00 AM EST - 3 months ago

STAAR Surgical Company (STAA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Feb 21, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating STAAR Surgical Company (STAA) And Encourages Investors to Connect

Feb 20, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages STAAR Surgical Company (STAA) Stockholders to Inquire about Securities Investigation

Feb 19, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against STAAR Surgical Company (STAA) and Encourages Investors to Learn More About the Investigation

Feb 18, 2025, 9:29 PM EST - 3 months ago

STAA Investors Have Opportunity to Join STAAR Surgical Company Fraud Investigation with the Schall Law Firm

Feb 18, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against STAAR Surgical Company (STAA) and Encourages Stockholders to Learn More About the Investigation

Feb 17, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages STAAR Surgical Company (STAA) Investors to Inquire about Securities Investigation

Feb 16, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against STAAR Surgical Company (STAA) And Encourages Investors to Reach Out

Feb 14, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against STAAR Surgical Company (STAA) And Encourages Stockholders to Reach Out

Feb 13, 2025, 10:00 AM EST - 4 months ago

Market Cap	861.75M
Revenue (ttm)	313.90M
Net Income (ttm)	-20.21M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-6.44%
Debt to Equity Ratio	0.00

Volume	918,600
Avg Vol	916,180
Day's Range	N/A - N/A
Shares Out	49.53M
Stochastic %K	54%
Beta	0.63
Analysts	Sell
Price Target	$17.62